TL938 and Trastuzumab for Patients With HER2-positive Metastatic Colorectal Cancer

Clinical trial NCT06589830 · RECRUITING

Trial details

NCT number: NCT06589830
Sponsor: Suzhou Teligene Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Metastatic Advanced Colorectal Cancer

Start date: 2025-05-13
Primary completion: 2026-10-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.